of pledge amounts that a project owner can request: fixed minimums, unspecified amounts, fixed overall amounts or multiple suggested amounts. Project owners will only receive the money they raised when they have reached their stated goal amount. This also means that the amounts that funders pledged will be cancelled if the total goal amount is not met. ScitechStarter allows projects to collect more than the goal amount by default, a process which is called overfunding. It is the discretion of the project owner to override this setting and disable overfunding.
Project funders can provide financial support for multiple projects and may receive RSS and feed updates from project owners. ScitechStarter also enables funders to post comments on projects and project updates and offer advice and assistance to project owners.
Additionally, as part of their agreement for using the website, project owners must devise project-related rewards for their funders. Suggestions for rewards include prototypes or models of products developed during the project, signed first copies of a science fiction novel, a meet-and-dine event with inventors, limited-edition gadgets, newly-discovered planets named after the funder and so on.
But Baylon is not stopping with the reward-based system. As the United States moves to make crowd investing legal in January 2013, he is developing the capability for ScitechStarter.com. "Whether you're a student, professional, faculty or someone with a curious mind, our goal is to make it easy as possible for you to start a project or fund your favorite ones," he said.
For more information, interested parties can contact ScitechStarter personnel at http://scitechstarter.com/contactus.
Contact:
Joseph Baylon
ScitechStarter
818-486-7899
info@scitechstarter.com
This press release was issued through eReleases
'/>"/>
SOURCE ScitechStarter Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 Related biology technology :1.
First Statewide Biotech Meeting Focuses on Patient Access, Innovation2.
Inverseon Focuses on Mucous and Smoking Cessation3.
Amarantus BioSciences Issues CEO Letter to Shareholders4.
BioSpace Spotlights Northwests Life Science Community5.
Amarantus BioSciences Secures $1.1 Million in Financing6.
IntelliCell BioSciences Announces It Will Present and Run Workshop at the 10th Annual Commercialization of Regenerative Medicine in London7.
Collegiate Inventors Honored for Innovative Science and Technology Advances8.
Caris Life Sciences mejora la evaluación por perfil molecular con los biomarcadores ROS1 y MGMT-metilación9.
Sapio Sciences Announces Exemplar LIMS for Tablet Computers10.
Caris Life Sciences Enhances Molecular Profiling Service with Addition of ROS1 and MGMT-Methylation Biomarkers11.
Correction: Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release